Mayo Clinic in Arizona
Scottsdale, Arizona, 85259, United States
NCT Number: NCT01822977
The investigators hypothesis is that daily use of a proton pump inhibitor (PPI) is associated with significant alterations in the healthy fecal microbiome that are similar to those seen in persons with an initial episode of clostridium difficile infection (CDI).
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Phase 1
Scottsdale, Arizona, 85259, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Table 1. Inclusion Criteria for Healthy Volunteers:
Table 2. Inclusion Criteria for Clostridium difficile infection subjects:
Table 3. Exclusion Criteria for Healthy Subjects:
Table 4. Prohibited Medications:
Time frame: 2 months
Time frame: 2 months
Mayo Clinic
Other
The Impact of Proton Pump Inhibitors on the Fecal Microbiome and Their Relationship to Clostridium Difficile Infection
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06068257
Breast Cancer, Breast Diseases
Orlando, Florida, United States
View Trial DetailsNCT06702423
Healthy
London, United Kingdom
View Trial DetailsNCT07223164
Healthy
Irvine, California, United States
View Trial DetailsNCT05595902
Healthy
Kadıköy, Istanbul, Turkey (Türkiye)
View Trial Details